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Rackgmwzd. lo the Cadence Tiered TBeherapy Dettbrittator, 
wheoatacbycardiasatt&s drte&nl criteria lur wdiouersion or 
detibrtttattw therapy, mgn cottage capaeimrs tqn cbhorging. The 
Cadeap defibrillator mnthues monitoring the rbyrbm durirrg 
charging and tf the mate derwaw to below the rate triggering 
tberqy, cbqing Q terminated. This event is registered @S an 
ab&ed shock. The deftbrUlator also bm the ability to stone 
iatracardix electrogrnm re?wdings of the electrical eww that 
9xecipttate device therapy or aborted shocks. 
Mdkods. During a man fottow-up interval of 10 t 7 months, 
55 &Wed eveots were &stered by the Cadenrp dedbrittator in 
18 dtbe 49 patients who received it. Thirty+~o stored ventricular 
ekctrogmms of even& Ieadttg to aborted shw!a were nvnilable 
la uulysis tn 15 patients. 
During 3 Btlo*-;p jxriod of 9 i 5 mordbs aIter tb&py WPP 
alterM no patient bad sebxmuent &r&d &o&s. Fire P&&S 
Conclusions. The ability of C&ore defibrttlator to coattow 
tachycaardia sensing durtng capaettw charging and to abort s&k 
therapy for selCterminating eve~~ts pwented una~c~~pry rho& 
in 18 (37%) ol the 49 p&i&. In(rPrardise ckctrwgnwn word- 
ings wvere critical for institutieg appropriate tbempy that may 
have prevented oooewssary device charging sod belie 
diitlarges. 
(I Am Coil Car&l 1~3;LI:89S-95@ 
Eespite the documented safety and efficacy of implantable 
eardioverter-defibrillator therapy. most devices are commit- 
ted to delivera shock once detection criteria are satisfied and 
the device begins charging. Termination of ventricular 
tochycardio during capacitor charging can result in a shock 
delivered during sinus rhythm. Third-generation implantable 
cardioverter-defibrillator devices otfer seveml advances in 
device therapy. iwluding the use of antitachycardia pacing 
with cardioversion and defibrillation shock capabilities 
(l-4). To avoid unnecessary implantzbk ~.~&erter- 
defibrillator shocks for self-terminating arrhythmias, the 
third-generation Cadence Tiered Therapy Defibrillator Sys- 
tern continues to monitor the rhythm during device charging 
to drtemline if the arrhythmia persists. If a n!e less than the 
rate Iripgering therapy is detected, char& is terminated 
immediately and no therapy is deliveicd. ‘IIds type of 
elecvical event is registered as an aborted shock in the 
Cadence system. Aborted therapy ca” occur only whtn the 
device has charged to deliver a shock, oat when antitachy- 
cardia pacing therapy is initiated. The purpose of our study 
was I) to detemdne the frequency of abated shocks doting 
foollow-up; 2) to evaluate the electrical events that precipi- 
tated the aborted shock: and 3) to determine ifreco&itioo of 
the electrical events could result in interventions designed to 
prevent subsequentelectri:aleventsleadingtaabartedshocks. 
Stody group. The study goup consisted of 49 patients 
who received a Venrritex Cadence Tiered Therapy Detihrtl- 
later System between August 1989 and September 1991 at 
the Hospital of the University of Pennsylvania. There were 
40mcsland9~n~thamennascof63*99(~ 
39 to 78). L& veutrlwler ejection r?ectbw tututed from 14% 
to 72% (mean 30 * 12%). Tbe et&uity of ptieots bad 
coronary artery diresse (Telde 1). l-be dhwmosis d tbe 
errhythmis zt the time of admission is fisted h Table 2. 
Patiatsre&wdacm&vortordehbriilatordcviceforther- 
spy of iife&eateniu# vetttricttiar arrhythmias after electro. 
physioi&c study-guided antiarriUtitmic dtug therapy ftdlod 
oriftbeypresentodwitbacatdiacertestandbadm 
inducible aubytbtoii doriug besehne eiectmphyshdogic 
testiou Wtients were M UD tbr a meau of IO * 7 
mot& (rattne 1 to 23) eftcr de& impiaotatiott. 
codmceTimndThera9yDdtbrimlt@rlpylpntptkamd 
to?@ A discussion of tito generai procedure for the im- 
plantaM ofc&iovorterdcMilators at the Hoqdtai oftbe 
Utdvenity of Pemwyfvauia has been doscrii in dstxil 
dsewbere (5). III tbs opwetiq mom. aitbsr a right ven- 
triuder epiEal tuutsvenous bipolsr e&co&l screw-in 
txtc@iead(n= 16)oraietIvetttticuiaropka~M~rew- 
in preitt9 iced (n = 33) was httpianted. Pacittn and sent& 
ulmsboids were 0lJtaitted and. wbett necessary. uto leads 
were tupositioucd b obtain satisfactoty thresholds. Satisfa+ 
tow sonsittnthroshoids were de6usd es en Pwave amaiitude 
t&rdod briug the patlent’s beseibte suprave&ttiar 
rbythmodzSmV~paFipL~rholdscl.5Va0.5ms 
y&e width Ddibtih&tt pet&es wem placed by ietanl 
tbomcotomy, typicoily witb ex anterior p&b positioned 
over tbe intravattriouiar septum and a fmstorior patch posi- 
tioned over the wstomiatetal ieft ventricular free wall. 
LtehbtNation t&holds were obtained with an extmoel 
dolibtiiiator (Ventritex HVS-02). When necessary, the 
@ches w:re repositioned to cbtaie optimei delibriiietion 
thresboids. 
The Cadence Tiered Tbmapy D&riiiator System can be 
contigttred to trout vetttricular flbrikation aiotte (a deiibrii- 
iator only) or to treat botb veutticuis tacbycardia and 
veniricuiar libriliation (an antitacbycmdii pacuueke~ 
lWk 1. Amhytbmia msis at AdmIssion 
c*rttlytlse 
cardlovwter and a delMUator). The devlcc is routinely 
progmeuued to deliver a shuck for an event that satisfies the 
9m2mmmedratecrltoriaforvoutriudarfibtiitiondotecticw 
tbat is appmximately IO J above the de&iiiatiffl tb~sbdd. 
EMore boqitel discbqe. vami&er t?briiietion attd, when 
epproptiate, vtwtrMar tucbycerdia were brduced to ceu- 
6rm the &icacy of devioo dehbtiiietiou and mttitacbycauXi 
pndqg e&itbttts. Six to 8 weeks efter discharge, the putieut 
rentrnod to the Hcqfitai of the university of Peousybmeia. 
Atrhythmi~ were again induced mtd thotepy &orithtos 
wore couibmed or modii. 
m ltag cqublutks md Mowup. Tlle veu- 
tritoxCudeuzeTieredTbcrauytMMll&rSystemCeealso 
store iutrscerdiec elm tcwrdingr&lectrical events 
tlwticadtodevicetherupy(6).Tberecordie$soreobtxiucd 
byau@ordialorcndocardiaibipolarratesensingiead 
5ystentnttdr#futetwiwitbabattdpttsscetttorodat30He 
The de& has mie stomge capacities for either 
one 64-s event, three 32s events or sevou 16s events. The 
stcmge tqwbilities mu u&rod by oitber &via tbmqy or 
redetectionofareteiosStbeutbepmgMnmdvoottSzldar 
tachycprdipcnloffretr.m~dngfotdccl~ 
gtamstoratteisforthroe32-smwtttawftbstora9s&fmrai 
by dote&on of a rate less than vo&ndar Mycwdia 
cutoRrato.Thont&tStydthedoviccsincurpatient~bad 
nondualekcuugramatomgesottinks. Uurbt9devicoitnpiau 
tetiottattdattitetimeufel&rqIbysioiogicovaiuetieubofore 
dimbm#cudat4weeks,realtimobfpofareloctmgrsm 
reand@sofskumrhytitmandaliiuducedetritytitmiaswere 
obtaiued. 
ThGVaarrileXC&DCCTEeredThe~Defibrillstasyb 
lcmrtmru2cmmbErd-. wdioveniwr& 
SUltiWyeudiapeebUaStemprslMdGiilldtbXllUolbaUf 
abortedsbocksZoreveryeiectrictdeveutitsoosestbat 
aat&lkoctft&forshockthaapy.Italsorecadsinttacur- 
diaceNrogmmsloreYeryekctsictdovontit8msestbat 
satis& ctiteria for devbw therapy, but only tbe very iest 
three eiectrictd evens cett be retrieved ftu elw 
tumiyair because of the Emits of its stomge oepochies. Tlws, 
if a patient hss more than three cLctrical events that initiated 
device tituapy, kttmcmdinc cl-8 from only the lest 
three events will be avaiiabie t?tr evaluation; the other 
cioctrlcal events will be nuted by the therapy they initiated 
(that is, Mbriiiation for en oiectriad ovwtt that sat&&d tim 
rate criterfa for vmttriotder %wiiiutiou deteotion, ruttitacby- 
car&apecionformeiectticeieveuttbutsttisiIedthcmte 
criterie for varid tachycerdie detection). 
aiial evahmtimt and device bttem@ion uere per- 
formedevery2moutbs.orassoonaspoudbieeftora 
symptomatic auitythmia episode Iluring thisevuluetion, tbe 
devioe was intertqated to detent,ue Stmrapy hiiory atuf lo 
recowuattystoroditttraeauIiaceiectronrmns.Ilci.#d&of 
tual time oiecttogrems of sinus rhytbttt ate obtained, us veil 
asstoredeloctrqremwoc&egsfromdevicota&otbwd 
uuy episode of spmuaemus veutrimdar finiuutiuu or vwu- 
tricular taebycardm. or k&b, dur& tbe ovaiuaticu. 
T&k 3. CharaEtesization of Events Receding Ahoned Shocb: 
.4aalv+ of Store.4 Ebx~rc~rams 
CvltwkfwrhytbmckwlReatlonamldebmalyPiP. Elec- 
trical CwtltS Were separsned into five cate&X tlOusur+ 
taincd utdharm veutricular tachycardia. rapid nousustaiucd 
polymotphic ventricular ~hycardiivcnuicular tlbrillation. 
atrial fib&tion, rcSular aopravcotricular tachycardii or 
dactrical noise uccordiu~ to the criteria Listed in Table 3. 
The aitcria listed in Table 3 BIP based on the finding (6.7) 
venviarlar tachycardia has been associated with a 
ZSe in local bipolar electmgrnm morpho@y 93% of 
ducumcuted epis&s at veutrlcufar taehycardii induced 
In the cluctrqthyabbfty laburatory or operating mom. 
The IimiWions associated with thcsc critaria arc that 
I) 7% of cpisodm of ventticular tuchycatdia have tbc same 
local CkctmSram mnpbolosy as that of rupravcnuicular 
rhythm,mxl2lacharqtcinlocalelfftroysmmorpbDkgy 
may occur with btutdk htanch block abermtiin ipsilatcral to 
the teclntlir@ lea&t dutitqt suptnvcntrkadar tachycardii 
17~.VariPbililyinthcRBiPtervslwsJnotuJedaspartaf 
the ctitcria fa d@osily oonrustaiaed ventticular tachy- 
cardia QutWueW clmupes In RR iutervalr in unimurphlc 
veraticular tachyatrdir may vaty by as much as 100 ma at 
the onset oftachycmdia (9). To demminc the cwmts tcadin$ 
to the aborted shocks, thrac obscrvws who had oo knowl- 
cd~c of the data rcvkwcd the rctricved intracardiac electro- 
matus. 
lndmm d n hwtd 5tmch During frdlav-up. 27 a- 
tiattshd4tX@odcsi~bythcVentritaxCadancc 
llctedThcmpy De6lwilbtwsyRtem a5 ventricular tachycar- 
dla ur vcutricular Rhrillation. One hundred thirty-five of 
there cpis&s kd to initial cardiov&tcr&Abrillatar shock, 
and 216 kd IO antitachycardia pack& The remainit& 55 
epiaodes kd to &uted shocks. whit occurred in IS pa- 
ti~andwillbsthef~~the~st~t~~~fl.Thetine 
&omdcvlcei@ant&utoalrortcdcvcutwas6~4moaths 
(l-a&c 1 to 14). 
Twenty-lhrcc efthe 55 &nrtal shock events b the 18 
patients were not avdabte tbrele*rcgrsm analysis bemuse 
of subscqacm arrhythmic cvcnts. The tcowining 32 evama 
available for elcctro~tam aoalysia acurrcd in 19 pa&n& in 
the other three yatieuts. elcctmgam recordiugs of tl~ 
aborted shucks were not available her the ekctru9ramu 
were replaced by other electrical cveuts. 
Of the 18 patients with abtuted events, 3 had cndueardii 
aod 15 had epicardii sctwin9 leads. The patients’ arcs 
rangedfmmSlta7ly~(mcpn~988)andIhc~~ 
fraction rat& from IS% to 72% (maan 32 + 14%). 
EMtcateventclendiu9toaMcdaha&‘fhethm 
obsarvan. who had no know& of patient data, uniformly 
ageed on the claxtiticatiou of the electro~tam rccotdht~s of 
the evmt lead@ tu the aburted shock in 26 @I%) of the 32 
episodes. Two of the three toviewcn spreed utt 6 (19%) of 
the episodes. and on a second. unblimkd review. a conscu 
sos was obtained for rhythm cla&cation by all three 
tcvicwers. Of the 32 events leadin to an aborted eWtt. IO 
wcm classifted as uonsustalned uniform veouieular tachv- 
tion, 2 as nooaastaiued polymo&ic Ventricular tachyc&iaJ 
vcntricutar hhrillation and I3 as consistent with tutttsient 
lead interruption fTable 4). l3xatnptcs of these cvcnts are 
showninFiirwlto4. 
Atmnthmtu- seean&Ttorcc@ttmdtha 
alKtrMcvalrtmd@tunbrokdaboek. afthe15paticnts 
with rccotdcd abmtcd shocks, 11 had their device repm- 
trammed. antiarrhytluoic aSnots added or lead adaytcr 
cha:tgd as a result cfthc i&mtatiott obtained hum amlysir 
of the stared intrxardii ekchu~rams aswciated with the 
abortcdshcckfMlc5).-llmdcviiwaarcprogrsmm#lin 
only4oftheIIpatients;anti~dnyltherapywas 
initiated in 1 patient. the device wan npm and 
antiarrhythmic drum therapy initiatad iu I and a Ractmcd 
lead adapter [II& WI 1) was rcplaccd in 5 ffablc 5). 
RdloW.up~~tbupP~~to~ 
shmla. lxtringrfolloWtp9etiod019*Jmonthlfran.9e2 
to19)&erchaageswcrcmadc,uo9atieuthadRt&r 
aborted shocks: hover, 6 uf the IS patients did have 25 
events Wing to device thctnpy. Five patimts had scvcn 
shocks delivered for ruataiucd vcnttiudar tachm con- 
Armcd by aoalysiu of stored imrseardiaf clccWBumS. SW- 
cntecn of the 25 tpiwaea wart sustained ventricular tachy- 
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Iwe < VT m4l RI. 
cardia nd were treated successfully with antitachycardia 
pacing. One patient had a single pisode ofparoxysmal atria1 
fibrillation precipitating inappropriate antitachycardia pac- 
ing. 
Discussiun 
Implantable cardioverter-defibrillators have been widely 
accepted aslife-saving therapy for many patients with seri- 
ous ventricular rrhythmias (10-12). Many studies have 
evaluated the number of device discharges after device 
implantation. A  inability in the past o precisely determine 
Figure 2. Example of nonsustained uniform ventricular tachycardia 
(VT). The I-s marker is located at the lower left. The morphology of 
the electrogram at the beginning of the tracing matched that of the 
real time electrograms obtained dmina normal sinus rhythm re- 
corded at the time of device implantation. The mean cycle length 
before the tachycardia episode equals 920 ms. The tachycardia 
begins suddenly, reaches the tachycardia cutoff rate (slanted arrow) 
and continues at a cycle length of 280 ms before converting to a 
supraventricular rhythm. The morphology of the local electrogram 
during tachycardia shows a large downward deflection, a huge 
upward deflection and again a large downward deflection and is 
clearly different from the morphology of the supraventricular 
rhythm in which a small downward deflection is followed by a large 
upward, downward and again upward deflection. 
NONSUSTAINED VENTRICULAR TACNVCARPIA 
Figure 1. Electrical artifact consistent wi:h 
disruption of the rate-sensing lead system. 
The I-s marker is located at the bottom left of 
the figure. The marker at right (arrow) signi- 
fies that the device has sensed a rate that is 
less than the ventriculartachycardiardia (VTJ cutoff 
rate. Supravenuicular hyuUn at a cycle !ength 
of 710 ms is seen both before and UD to and after 
this marker. The rapid high frcqiency spikes 
that bear no resemblance to the morphology of 
the electrogmms recorded during supraventric- 
ular rhythm are electrical artifact. 
the cause of the device discharges has limited the adequate 
evaluation of patient outcome (IO). This inability also has 
limited potentially helpful alterations in therapy, especially 
when the device reacts to a rapid nonlife-threatening ar- 
rhythmia. That Ventritex Cadence Tiered Therapy Defibril- 
lator System can store recorded intracardiac electrogmms 
from one, three or seven events, depending on device 
programming, that rigger device therapy (including device 
charging). 
Our study showed that in 37% of patients, continued 
sensing during defibrillator charging prevented unnecessary 
shocks that might have occurred incommitted devices. The 
device recognized episodes of nonsustained ventricular 
tachycardia (n = lo), nonsustained polymorphic ventricular 
tachycardia/ventricular fibrillation (n = 2). supraventricular 
tachycardia (n = 2), attiai fibrillation (n = 5) and electrical 
noise (n = 13) as self-limited pisodes not requiring detibril- 
lation therapy. 
Several of the third-generation implantable cardioverter- 
defibrillators (Medtronic PCD 7217B. Intermedics Res-Q, 
Siemens-Pacesetter Siecure) are committed to deliver a 
shock once they detect a rapid rate (more rapid than the 
programmed v ntricular fibrillation cutoff rate) regardless of 
its duration (3). Three devices (CPI PRx. Telectronic Guard- 
ian ATP 4210 and Ventritex Cadence) reevaluate the 
rhythm, after the capacitors are charged but before the 
device is discharged and have the ability to withhold therapy 
if the rate has fallen below the ventricular fibrillation cutoff 
rate (3). Only with the Ventritex Cadence Tiered Therapy 
Defibrillator System isthis undelivered shock recorded and 
are the data vailable for retrieval. 
Other implantable cardioverter-defibrillators can retrieve 
the arrhythmias nitiating device therapy, but these are in the 
form of rate counters orRR intervals or include the electro- 
grams from only a few (not 30) seconds during the detected 
episode. The ability to precisely determine the cause of the 
aborted shock with the retrieved electrograms allowed us to 
appropriately intervene with a lead adapter replacement 
when eeded (for electrical noise), device reprogramming or 
antiarrhythmic agent alterations, or both (for supraventricu- 
lar tachycardia, nonsustained ventricular tachycardia and 
atrial fibrillation), ornot to change therapy for nonsustained 
polymorphic ventricular tachycardialventriculr,r 6brGatiun. 
3 
The electrical noise that was recorded and that initiated 
an aborted event identified patients who had intermittent 
lead disruption. This was secondary to problems that oc- 
curred with the Da@ adapter placed bclwcen the epicsrdial 
I ‘- I 
sensing leads and the device itself. The heada nf the 
Ventritex Cadence device will accept only in-Iii bipolar 
Iti and needs au edapter to camect to the cpicardhd 
sensing Icads. No patient has died as a mit o! rhc c&~pvr 
breaks. but paticnta have used their deflbrittwor to trcm 
sustained vemrtcular ahycardia after Ihe adnpter was rr- 
placed. Had the many e&odes of noise been sensed and 
rewrded as ~ennicular EbriUatkm by RR interval counters, 
appmprtate inlewention to mphux the disrupted ad@er 
wwld ucdcak4iy have been delayed. with potenti& 
disastrous consequences. Because adapters are only neat 
arywhenepicardiiscnsingkndsurused.wenuwuse 
only endoadii seasing leads with the Veatritcx Cadence 
Tii Therapy De6brillamr System. essatiaUy eliroinatipg 
lhissoIwxforabMtedshocks. 
Tile ability lo di&renliate alrial f&briuatiun from noo*u+ 
mined vetnricular locbywdii can ako be help&l in pro- 
gamming the device for epti4 function. ‘Ibe pesence of 
atrial LrNation can usually be rklermined by usiw RR 
interval counten ood intracardir elearagam recording, 
because ai its irtqula~ rote (13). However. because nonsuk 
lained ventricular taehycmdia c3n al&e very ifrqp~lar, it is 
helpful 10 have an eluxmgmm morphubgy duriry the ar- 
rhythmio Ihal matches real lime B duriw sinus 
rhylhm wheo avial &uillation is diapme& Whawver the 
caundIheaburtedshuck.mco&ionof~he-ovents 
appear to allow ml inlwediun tbat pravents subsoquenl 
unnecessary chargiog of the implaotable cardioverter- 
dChbrillrtor.AdeenarciDlhe~oflimgIhe&viee 
chargcsCanpacllli8UYiiWBebaaeryliiandlongevayof 
the unii. 
LlmlloUom of lha stody. Mhoum the combbmtioa of 
atwtive shuck apahilhy and electro~m storage of fhe 
&ctrkol events let&~ to the aborted shock therapy is 
helpcul. there are limiionr to its usefulness. T&et= are 
fmmWm2Xlinl: 
UOmJWmsinII 
patha io whom tbe decmg171~1 mwphdcgy is similar 
duiing slnus rilytbm aod ventriMlar lachycaniia (7). As 
nuted. appmximstcly 7% of episcdes of vaWular IachP 
cardia have the same elcctrogmm murphabgy as that 
of supmveatricular rhythm aixl a chaage in local elac- 
tnxram marphobgy may occur with bundle brunch absrra- 
tIci during -xq&&n& tachycardia (8). This would 
limit the ability tu diirantiate adequately w~ven&ic- 
ular tachycordi~al6briWon from ventricular tachycar- 
dia. Tbe availability of electrogam remrdbqs from wide 
bipolar electrode p&s may provide supplemental ilbur- 
mation that may improve the diagnostic capability of 
elcctmgram sloragc information. pipally. although no 
aborted shocks occurred during the follow-up period 
d9 i 5 mciuha alIar therapy or device ppogmnmiag was 
changed, this period may nut be long enough to kaow 
whether UIM altwations (Table 5) bad a clinically signi&zm~~ 
e&l. 
Qndusioaa. WC showed that I8 07% of49 patients whh 
the Vent&x Cadence Tiered Thcsapv Ddibrillator SWm 
bad aborted shocks du@ a fdlo&up period uf 16 t 7 
mualhr. The most common anhytbmia resultim ia an 
aborted shack was rumsustained ventricular tachycardla. 
The system’s ability KI eecord at&ad shocks was extremely 
MplY in allowing u* tu improve OUT patients’ therapy nnd ta 
limltuMewss&uyeharOiagdthedevice.Ttdswasparlicu- 
tarly true fur tlxxe patients who had abort-lived electticnl 
noise that triggered an aborted shuck. Diagnusis d potential 
kad dirrupdoa allowed immediate surgical raplaccment of 
tbe lead adnpter. Thus, the combiaatim~ of abortive shack 
capsbiMy with elm storage of the electrical mata 
kading !o the aborled therapy is an impartant advance in 
implantable cardio~~&librilla~ therapy. 
